Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-8025 Phase II Study in COPD Patients
jRCT2080221718Phase 2
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Imidafenacin (ONO-8025) with Placebo (2 arms).
02
Drugs
imidafenacin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT2080221718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221718.